JEOL USA Welcomes New Managing Director, Hidetaka Sawada

April 19, 2021 Peabody, Mass. — JEOL USA welcomes a new Managing Director, Dr. Hidetaka Sawada, to its Peabody, Massachusetts office this April. Dr. Sawada is a world-renowned expert in aberration corrected electron microscopy. Most recently he served as General Manager of the Technical and Development group in the Electron Microscopy Business Unit of JEOL,... Read more

PerkinElmer Supports PROXIDRUGS Consortium Aimed at Advancing Targeted Protein Degradation/PROTAC Drugs

Leading academic and industry cluster to help address 80% of disease-relevant human proteins currently undruggable WALTHAM, Mass. – April, 21, 2021 PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it is serving as a provider and co-developer of assays, instrument solutions and expertise for the PROXIDRUGS Consortium which... Read more

PerkinElmer to Present at BofA Securities 2021 Virtual Health Care Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 21, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 9:30 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide... Read more

Roche reports solid results in the first quarter of 2021

Basel, 21 April 2021 Group sales increase 3%1 at constant exchange rates (CER); 1% decline in Swiss francs, as a result of the appreciation of the Swiss franc Pharmaceuticals Division sales: Continued strong growth of new medicines (+20%) As expected, significant impact from biosimilars (CHF -1.6 billion) Base effect from the strong first quarter 2020... Read more

Introducing ORG.one: a project to support rapid DNA sequencing of critically endangered species

Mon 19th April 2021 ORG.one is a pilot-stage project designed to support faster, more localised sequencing of critically endangered species, by enabling biologists to rapidly sequence those species close to the sample’s origin, using the latest ultra-long read approaches from Oxford Nanopore.​ Loss of biodiversity is an urgent problem. Genomics can help with existing conservation work, as well as securing the DNA sequence of... Read more

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year

SANTA CLARA, Calif., April 20, 2021  Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes’s 2021 list of America’s Best Employers... Read more

Thermo Scientific Helios 5 EXL Wafer DualBeam Offers Automation in TEM Sample Prep to Help Accelerate Time-to-Yield

Thermo Scientific Helios 5 EXL Wafer DualBeam Offers Automation in TEM Sample Prep to Help Accelerate Time-to-Yield HILLSBORO, Ore., April 20, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today unveiled the Helios 5 EXL Wafer DualBeam, designed to meet increasing sample volumes and analysis needs of semiconductor manufacturers as they scale... Read more

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company founded to accelerate early screening of cancer. Illumina will continue to work with the Directorate-General to bring the investigation to conclusion. Illumina remains committed to the transaction, the... Read more

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., April 19, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 second quarter which ended on March 31, 2021 on Monday, May 10, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis

85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity (NEDA) in open-label Phase IIIb ENSEMBLE study OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study OCREVUS-treated patients show highest adherence and persistence rates... Read more